All Type of News
Push-in activities to pharmaceutical distribution companies
The industry has paid attention as pharmaceutical companies’ push-in activities have increased.
According to the industry concerned on the 28th, pharmaceutical companies have pushed in a large amount of products in a...
Deputy Minister Moon-gi Sohn promoted to Minister of Food and Drug Safety
Deputy Ministry Moon-gi Sohn was promoted to the 3rd Minister of Food and Drug Safety(MFDS).
President Geun-hye Park promoted the current Deputy Minister of Food and Drug Safety to the Minister of Food and Drug Safet...
Teva-Handok acquires domestic approval of asthma/COPD therapyA Handok-Teva’s(CEO Sun-dong Park) asthma and chronic obstructive pulmonary disease(COPD) treatment, Duorespi Spiromax(generic name: budesonide/formoterol) acquired approval fro...
|
‘Clinic management is even harder than what was shown in statistics’
The medical association has started to prepare for the insurance cost negotiation. Its insurance cost negotiation group plans to focus on the reality of medical clinics in trouble for the negotiation.
The Korean Med...
Will MSD get out of NIP if their prices are unified?It’s a very tough situation. The government has shut their mount, and the two pharmaceutical companies concerned have shown no sign to shorten their gap in opinion.
This is the...
|
Trending ‘biologics’ confuse patients due to complicated insurance benefit standards
Biologics, having low side effects and proved in efficacy for a long term, may nurture haters. This is because a number of patients have made complaints due to its complicated insurance benefit standards.
Biologics h...
Januvia family becomes King of ETC drugs over other antidiabetics
MSD Korea’s(CEO Dong-wook Hyun) diabetes type 2 treatments, the Januvia family has made the top of the 2015 4th quarter’s ETC market(based on the IMS’s amount of outpatient prescriptions).
The Januvia family, consist...
Obligation of latent-tuberculosis examinations
The government announced it held the 80th National Policy Coordination Meeting hosted by Prime Minister Kyo-ahn Hwang on the 24th, and discussed and confirmed the ‘Execution Plan for Tuberculosis-Free Country’ and ‘20...
Countdown begins for 3rd generation lung cancer drugs among Hanmi, BI and AZ
Competed by Hanmi Pharm, Boehringer Ingelheim and AstraZeneca, launches of the 3rd generation non-small cell lung cancer treatments have begun a countdown.
According to the Ministry of Food and Drug Safety(MFDS) and...
Chronic hepatitis C treatments, Sovalid and Harvoni passes the first door
Chronic hepatitis C treatments, Sovaldi(sofosbuvir) and complex Harvoni(sofosbuvir, ledipasvir) have passed benefit adequacy evaluations.
This is a great news for the patient group damaged by the Dana Clinic crisis. ...
